Integra Lifesciences Holdings (IART) Research & Development (2016 - 2026)
Integra Lifesciences Holdings' Research & Development history spans 17 years, with the latest figure at $24.8 million for Q4 2025.
- On a quarterly basis, Research & Development fell 20.57% to $24.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $99.0 million, a 14.22% decrease, with the full-year FY2025 number at $99.0 million, down 14.22% from a year prior.
- Research & Development hit $24.8 million in Q4 2025 for Integra Lifesciences Holdings, up from $22.5 million in the prior quarter.
- Over the last five years, Research & Development for IART hit a ceiling of $31.2 million in Q4 2024 and a floor of $20.1 million in Q2 2021.
- Historically, Research & Development has averaged $25.6 million across 5 years, with a median of $25.7 million in 2021.
- Biggest five-year swings in Research & Development: soared 34.81% in 2021 and later fell 20.57% in 2025.
- Tracing IART's Research & Development over 5 years: stood at $24.7 million in 2021, then increased by 8.32% to $26.8 million in 2022, then fell by 9.33% to $24.3 million in 2023, then grew by 28.52% to $31.2 million in 2024, then fell by 20.57% to $24.8 million in 2025.
- Business Quant data shows Research & Development for IART at $24.8 million in Q4 2025, $22.5 million in Q3 2025, and $27.0 million in Q2 2025.